放疗期间FDG PET/CT用于肺癌靶区勾画
基于4项前瞻性研究共67例非小细胞肺癌患者(51个原发肿瘤、60个淋巴结),在放疗第5周行FDG PET/CT,提出仅基于SUVmax的perPET-RT勾画法,并与8种固定阈值法和3种自适应阈值法比较。perPET-RT与金标准一致性良好至很好,肺病灶DSC均值0.81±0.13、淋巴结0.78±0.15,除一种自适应阈值法ADT(p=0.11)外优于其他方法(p<0.001)。作者认为该方法可用于剂量递增计划的肿瘤体积勾画。
要点
- perPET-RT勾画法验证了最优阈值表达式Thopt=A.ln(1/SUVmax)+B,常数A、B与PET/CT代次无关但取决于病灶类型(原发肺肿瘤vs淋巴结)。
- perPET-RT与金标准一致性良好至很好,DSC均值:肺病灶0.81±0.13、淋巴结0.78±0.15。
- 除自适应阈值法ADT(p=0.11)外,perPET-RT一致性显著优于其他分割方法(p<0.001)。
核心结论
- 在所用数据库上,perPET-RT仅用SUVmax测量即证明了其在放疗期间FDG PET/CT上肿瘤勾画的可靠性和准确性。
- 作者认为该方法可用于剂量递增计划的肿瘤体积勾画。
研究设计与样本
- 来自4项前瞻性研究的67例非小细胞肺癌患者(51个原发肿瘤、60个淋巴结),在放疗第5周使用不同代次PET/CT行FDG PET/CT扫描。
- 由两名经验丰富的医师共识勾画放疗中PET/CT作为金标准阈值,确定最优阈值Thopt作为SUVmax函数的数学表达式。
- 通过计算DICE相似系数(DSC)评估perPET-RT性能,并与8种固定阈值值和3种自适应阈值法比较。
主要发现
- Thopt验证了表达式Thopt=A.ln(1/SUVmax)+B,其中A和B为2个常数。
- A和B与PET/CT代次无关,但取决于病灶类型(原发肺肿瘤vs淋巴结)。
- perPET-RT与金标准相比显示良好至很好的一致性,DSC均值±标准差为肺病灶0.81±0.13、淋巴结0.78±0.15。
- perPET-RT一致性显著优于其他分割方法(p<0.001),但一种自适应阈值法ADT除外(p=0.11)。
关键数值与推荐
- 最优阈值表达式:Thopt=A.ln(1/SUVmax)+B,A和B为2个常数。
- DSC均值±标准差:肺病灶0.81±0.13,淋巴结0.78±0.15。
- 与8种固定阈值法和3种自适应阈值法比较,除ADT(p=0.11)外差异均显著(p<0.001)。
临床怎么用
- 作者认为perPET-RT可用于剂量递增计划的肿瘤体积勾画。
局限性
- 原文结论限定为「在所用数据库上」perPET-RT证明了其可靠性和准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To propose an easily applicable segmentation method (perPET-RT) for delineation of tumour volume during radiotherapy on interim fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in patients with non-small cell lung cancer (NSCLC). MATERIAL AND METHODS: Sixty-seven patients (51 primary tumours, 60 lymph nodes), from 4 prospective studies, underwent an FDG PET/CT scan during the fifth week of radiation therapy, using different generations of PET/CT. Per-therapeutic PET/CT scans were delineated in consensus by two experienced physicians leading to the gold standard threshold to be applied. The mathematical expression of Thopt, the optimal threshold to be applied as a function of the maximum standard uptake value (SUVmax), was determined. The performance of this method (perPET-RT) was assessed by computing the DICE similarity coefficient (DSC) and was compared with 8 fixed threshold values and 3 adaptive thresholding methods. RESULTS: Thopt verified the following expression: Thopt = A.ln(1/SUVmax) + B where A and B were 2 constants. A and B were independent from the generation of PET/CT, but depended on the type of lesions (primary lung tumours vs. lymph nodes). PerPET-RT showed good to very good agreement in comparison to the gold standard. The mean and standard deviation of DSC value was 0.81 ± 0.13 for lung lesions and 0.78 ± 0.15 for lymph nodes. PerPET-RT showed a significant better agreement than the other segmentation methods (p < 0.001), except for one of the adaptive thresholding method ADT (p = 0.11). CONCLUSION: On the database used, perPET-RT has proven its reliability and accuracy for tumour delineation on per-therapeutic FDG PET/CT using only SUVmax measurement. This method may be used to delineate tumour volume for dose-escalation planning. TRIAL REGISTRATION: NCT01261598 , NCT01261585 , NCT01576796 .
引用
- Ganem J, Thureau S, Gardin I, et al. Delineation of lung cancer with FDG PET/CT during radiation therapy. Radiat Oncol. 2018. PMID: 30419929. doi:10.1186/s13014-018-1163-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。